1887

n Cardiovascular Journal of South Africa - New pathophysiological insights explain life-saving benefits of perindopril in coronary artery disease patients : drug trends in cardiology

USD

 

Abstract

Extracted from text ... 248 Drug Trends New pathophysiological insights explain life-saving benefits of perindopril in coronary artery disease patients The long-acting angiotensin-converting enzyme (ACE) inhibitor perindopril (COVERSYL(r)) significantly reduces the risk of cardiovascular death and myocardial infarction in patients with stable coronary artery disease, not only via a reduction in blood pressure, but also by a direct vascular and antiatherosclerotic effect. This is revealed by new results from the EUROPA (EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease) study, announced for the first time today at the European Society of Cardiology (ESC) annual congress.1 The blood pressure ..

Loading

Article metrics loading...

/content/cardio/15/5/EJC23943
2004-09-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error